Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Université de Montréal
$120,000.00
Identification of neuronal processes underlying the fatty acid synthase-related developmental and epileptic encephalopathy
EF 2025-26
Résumé
Developmental and epileptic encephalopathies (DEEs) are severe childhood brain disorders in which seizures impair development and quality of life. In 2014, researchers identified a possible link between mutations in the gene FASN and a new form of DEE. This gene produces fatty acid synthase (FAS), the protein that enables the body to make its own fatty acids. FAS activity is essential for brain growth, the generation of new neurons, and proper myelin, the fatty insulation that allows neurons to communicate efficiently. Additionally, mutations in fat-related genes similar to FASN can cause neurodegeneration with brain iron accumulation (NBIA), a devastating condition that worsens with age. Alarmingly, FASN-related DEE has not been characterized, and its relationship with NBIA remains unknown. My PhD project aims to address this gap. Together with clinicians worldwide, we have gathered data on 29 patients. I have curated and analyzed the data, showing that FASN mutations can indeed lead to DEE, movement problems and other signs that overlap with NBIA. Our laboratory has developed a mouse model carrying a patient's mutation. My experiments showed that mutant mice have reduced FAS activity, suggesting that pharmacologically increasing it could be a treatment strategy. Using advanced tools, including electron microscopy, brain fat profiling, single-cell sequencing, and histology, I will study how impaired fatty acid production alters myelin, neuron generation, and brain development and aging, thereby clarifying the biology of FASN-related DEE. Our research will improve diagnosis and prognosis for affected families. More broadly, we will generate knowledge about how the brain's own fatty acid production supports development and prevents degeneration, benefiting patients in Canada and worldwide.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
559375
Name
Hermida Borroto Maria C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Identification of neuronal processes underlying the fatty acid synthase-related developmental and epileptic encephalopathy
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Epilepsy; Fatty Acid Synthase; Lipidomics; Mouse Models; Myelination; Neurodegeneration; Neurodevelopmental Disorders; Rare Genetic Syndromes; Single-Cell Transcriptomics; Translational Neuroscience
Abstract
Developmental and epileptic encephalopathies (DEEs) are severe childhood brain disorders in which seizures impair development and quality of life. In 2014, researchers identified a possible link between mutations in the gene FASN and a new form of DEE. This gene produces fatty acid synthase (FAS), the protein that enables the body to make its own fatty acids. FAS activity is essential for brain growth, the generation of new neurons, and proper myelin, the fatty insulation that allows neurons to communicate efficiently. Additionally, mutations in fat-related genes similar to FASN can cause neurodegeneration with brain iron accumulation (NBIA), a devastating condition that worsens with age. Alarmingly, FASN-related DEE has not been characterized, and its relationship with NBIA remains unknown. My PhD project aims to address this gap. Together with clinicians worldwide, we have gathered data on 29 patients. I have curated and analyzed the data, showing that FASN mutations can indeed lead to DEE, movement problems and other signs that overlap with NBIA. Our laboratory has developed a mouse model carrying a patient's mutation. My experiments showed that mutant mice have reduced FAS activity, suggesting that pharmacologically increasing it could be a treatment strategy. Using advanced tools, including electron microscopy, brain fat profiling, single-cell sequencing, and histology, I will study how impaired fatty acid production alters myelin, neuron generation, and brain development and aging, thereby clarifying the biology of FASN-related DEE. Our research will improve diagnosis and prognosis for affected families. More broadly, we will generate knowledge about how the brain's own fatty acid production supports development and prevents degeneration, benefiting patients in Canada and worldwide.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hermida Borroto, Maria C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~